Newsletter No. 85 -- March 2006
NIH - New Funding Initiatives
1. SMALL ANIMAL IMAGING RESOURCE PROGRAM (U24) (NCI)(RFA-CA-07-004),
Letter of Intent Receipt Date: April 18, 2006
Application Receipt Date: May 18, 2006
The NCI invites applications from extramural investigators for Small Animal Imaging Resources (SAIRs). These grants will support: (a) shared imaging resources to be used by cancer investigators; (b) research related to small animal imaging technology or methodology; and (c) training of both professional and technical support personnel interested in the science and techniques of small animal imaging. Small Animal Imaging Resources (SAIRs) will enhance capabilities for conducting basic, translational, and clinical cancer research relevant to the mission of the NCI. Major goals of this initiative are to increase efficiency, synergy, and innovation of such research and to foster research interactions that cross disciplines, approaches, and levels of analysis. Building and strengthening such links holds great potential for better understanding cancer, and ultimately, for better treatment and prevention. The application implements the new multiple-PI policy (http://grants.nih.gov/grants/multi_pi/).
2. PHS 2006-02 OMNIBUS SOLICITATION OF THE NIH, CDC, AND FDA FOR SMALL BUSINESS INNOVATION RESEARCH GRANT APPLICATIONS (PA-06-120) AND PHS 2006-2 OMNIBUS SOLICITATION OF THE NIH FOR SMALL BUSINESS TECHNOLOGY TRANSFER GRANT APPLICATIONS (PA-06-121)
URL (Parent SBIR [R43/R44]): http://grants.nih.gov/grants/guide/pa-files/PA-06-120.html
URL (Parent STTR [R41/R42]): http://grants.nih.gov/grants/guide/pa-files/PA-06-121.html
3. NIH PATHWAY TO INDEPENDENCE (PI) AWARD (K99/R00) (PA-06-133)
Application Receipt Dates: April 7, 2006 and then standard dates.
This initiative will develop and implement a new Pathway to Independence Award Program (PI) designed to facilitate receiving an R01 award earlier in an investigator's research career. The primary, long-term goal of the PI Award Program is to increase and maintain a strong cohort of new and talented, NIH-supported independent investigators. The Pathway to Independence Award will provide up to five years of support consisting of two phases. The initial phase will provide 1-2 years of mentored support for highly promising, postdoctoral research scientists. This phase will be followed by up to 3 years of independent support contingent on securing an independent research position.
4. NANOMEDICINE DEVELOPMENT CENTERS (PN2) (RFA-RM-06-007)
Concept Approval Letter Receipt Date: March 15, 2006
Application Receipt Date(s): June 23, 2006
Nanomedicine is one of nine major initiatives included in the NIH Roadmap. Because Nanomedicine is an emerging biomedical discipline, the NIH engaged the biomedical research community to help define and develop concepts and a framework to stimulate work in this field. A two-year planning process, (see http://grants1.nih.gov/grants/guide/rfa-files/RFA-RM-04-018.html) culminated in the establishment of acollaborative national network of Nanomedicine Development Centers (NDC). The first four centers were awarded in fiscal year 2005. The current RFA solicits applications for additional centers that will expand the network by addressing complementary models, topics, medical targets, and approaches to the work of funded centers.
URL: for Concept Approval Letter Evaluation Information: http://grants.nih.gov/grants/guide/notice-files/NOT-RM-06-014.html
5. INTERDISCIPLINARY RESEARCH CONSORTIUM (U54)
PREAPPLICATION FOR INTERDISCIPLINARY RESEARCH CONSORTIUM (X02)
Dates: LOI: March 21, 2006; Preapplication: Arpil 18, 2006 - Use SF-424 Electronic Submission.
The Interdisciplinary Research Implementation Group will invite applications for Interdisciplinary Research Consortia from among those that submit a pre-application in response to PAR-06-122. This RFA with Limited Eligibility for a full consortium is released early to aid those who are writing a pre-application. Only those selected through a peer review of their pre-application are eligible to apply for a full Interdisciplinary Research Consortium. The purpose of this program is to support interdisciplinary approaches to solving significant and complex biomedical problems, particularly those that have been resistant to traditional approaches. These applications must hold the promise of leading to new research approaches to improving human health. Interdisciplinary consortia are expected to identify an important biomedically relevant problem, evaluate why previous approaches have not worked, justify why the proposed interdisciplinary approach will work, identify the methods that will keep the interdisciplinary team focused and coordinated, and propose a timeline. The review criteria will involve both the significance of the problem as well as the interdisciplinary nature of the approach to solving the problem. Applications will have to be strong in both of these areas. A successful interdisciplinary approach is defined as combining aspects of individual disciplines to provide a new conceptual approach to solving a problem that is likely to yield insights that could not have been achieved by an isolated laboratory or using a multi-disciplinary approach. URL for Consortium RFA: at http://grants.nih.gov/grants/guide/rfa-files/RFA-RM-06-008.html
URL for Preapplication: http://grants1.nih.gov/grants/guide/pa-files/PAR-06-122.html
URL for Addendum: http://grants.nih.gov/grants/guide/notice-files/NOT-RM-06-011.html
6. EXTENSION OF BIOENGINEERING RESEARCH GRANT (BRG) PROGRAM ANNOUNCEMENT (PA-02-011) (NOT-EB-06-006)
7. TUMOR MICROENVIRONMENT NETWORK (TMEN) (U54) (RFA-CA-06-014)
Letter of Intent Receipt Date: April 10, 2006
Application Receipt Date: May 10, 2006
The NCI invites cooperative agreement and NIH intramural applications from groups of investigators interested in becoming components of the NCI Tumor Microenvironment Network (TMEN). The main objective is to delineate mechanisms of tumor-stroma interactions in human cancer and to generate a comprehensive understanding of composition of the stroma in normal tissues as well as its roles in tumor initiation, progression, and metastasis. URL: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-06-014.html
8. NON-INVASIVE METHODS FOR DIAGNOSIS AND PROGRESSION OF DIABETES, KIDNEY, UROLOGICAL, HEMATOLOGICAL AND DIGESTIVE DISEASES (R21) (NIDDK) (PA-06-142)
This funding opportunity announcement (FOA) is a call for the application of imaging and other non- or minimally-invasive technologies to detect, characterize, diagnose, identify persons with predisposition to, or monitor treatment of diseases of interest to the NIDDK. Also needed are new, robust surrogate markers for clinical trial endpoints, and new ways to characterize normal and pathological tissues in vivo. Diseases of interest include type 1 and 2 diabetes, obesity, and kidney, liver, urologic, hematologic, digestive, endocrine and metabolic diseases and their complications. Applicable techniques include molecular imaging and functional imaging approaches, imaging methods with high spatial, chemical or time resolution, and new spectroscopic or sensor array technologies for monitoring metabolic or physiological events.
9. INNOVATIVE AND EXPLORATORY RESEARCH IN DIGESTIVE DISEASES AND NUTRITION (R21) (NIDDK, NCI, ODS) (PA-06-149)
The NIDDK and the Division of Cancer Prevention at the NCI invite applications through the exploratory/developmental (R21) grant mechanism from investigators with research interests in gastroenterology, hepatology, obesity, and nutrition and that serve the mission of NIDDK and NCI. The aim of this funding opportunity is to stimulate the application of highly novel approaches to important areas of digestive diseases (including associated cancers) and nutrition research. Areas of special interest in this funding opportunity include development of novel non invasive imaging methods to study function of the gastrointestinal tract, liver, pancreas and adipose tissue and pathogenic processes such as fibrosis, inflammation, hyperplasia, fat body accumulation.
10. AAPM 2006 SUMMER UNDERGRADUATE FELLOWSHIP PROGRAM
Deadline: March 11, 2006
NIH OFFICE OF EXTRAMURAL RESEARCH ANNOUNCES THE NIH EXTRAMURAL NEXUS BIMONTHLY UPDATE (NOT-OD-06-032)
The first NIH Extramural Nexus will be sent to all NIH Guide subscribers sometime in the next few days. The Nexus will be distributed six times annually and will provide the biomedical research community with updates on NIH extramural research programs, activities, and policies.
NIH ADJUSTS TIMELINE FOR ELECTRONIC APPLICATION SUBMISSION TO PROVIDE ADDITIONAL TIME BEFORE THE R01 TRANSITION (NOT-OD-06-035)
February 1, 2007 is the current date planned for the transition (as of March 2006).
URL for Electronic Submission of Grant Applications: http://era.nih.gov/ElectronicReceipt/index.htm
CHANGE IN FUNDING OPPORTUNITY ANNOUNCEMENTS THAT USE R03, R21, R33, AND R34 GRANT MECHANISMS: TRANSITION TO ELECTRONIC SUBMISSION USING SF424 (R&R) GRANT APPLICATION PACKAGE(NOT-OD-06-046)
UPDATES TO NIH'S ELECTRONIC APPLICATION SUBMISSION PROGRAM AVAILABLE THROUGH LISTSERV SUBSCRIPTION (NOT-OD-06-047)
ESTABLISHMENT OF MULTIPLE PRINCIPAL INVESTIGATOR AWARDS FOR THE SUPPORT OF TEAM SCIENCE PROJECTS (NOT-OD-06-036)
In 2006 the National Institutes of Health (NIH) will begin to implement a Federal-wide policy to allow formally more than one Principal Investigator (PI) on individual research awards. This presents a new and important opportunity for investigators seeking support for projects or activities that clearly require a "team science" approaches and which do not fit the single-PI model. The multiple-PI model is intended to supplement, and not to replace, the traditional single PI model. The overarching goal is to encourage collaboration among equals when that is the most appropriate way to address a scientific problem. Although the number of applications submitted with more than one PI is expected to be relatively small compared with those that continue to use the traditional single-PI format, we know that the impact on multidisciplinary efforts may be great. A Multiple Principal Investigator website (http://grants.nih.gov/grants/multi_pi/) has been created to provide general information on the new policy. This includes: background and features of the multiple-PI policy; major issues to be considered in its implementation; PI roles and responsibilities; distribution of credit; allocation of funds; and awards to more than one institution.
RAPID ACCESS TO INTERVENTION DEVELOPMENT (RAID)(NOT-CA-06-005)
The NATIONAL CANCER INSTITUTE (NCI) is requesting project proposals in response to the Rapid Access to Intervention Development (RAID) Program. The RAID Program makes available to academic investigators, on a competitive basis, the preclinical development contract resources of NCI's Developmental Therapeutics Program (DTP). RAID is not a grant program. For information on the procedures for requesting RAID resources and for electronically filing a RAID proposal, visit the DTP web site at http://dtp.nci.nih.gov/. Inquiries are encouraged and DTP staff members welcome opportunities to clarify issues or to answer questions about the RAID program.
SALARY LIMITATION ON GRANTS, COOPERATIVE AGREEMENTS, AND CONTRACTS(NOT-OD-06-031) URL: http://grants.nih.gov/grants/guide/notice-files/NOT-OD-06-031.html
SCIENTIFIC CURATOR - NIH IMAGING AGENT DATABASE
Computercraft seeks an experienced imaging scientist to provide curatorial responsibilities for implementing and maintaining the NIH imaging agent database. The individual will work with NIH staff scientists and extramural advisors onsite at the NIH campus. Join our team of highly skilled and dedicated professionals as we participate in the development of a new centralized database of in vivo imaging agents. This innovative database will include agents developed for position-emission tomography (PET), single-photon emission computed tomography (SPECT), magnetic resonance imaging (MRI), ultrasound and optical imaging. The database will be located within the National Center for Biotechnology Information (NCBI) at the National Institutes of Health (NIH). This diversified and challenging position requires a Ph.D. (strongly preferred) or M.S. degree in imaging sciences or highly related field. The successful candidate will have a demonstrable knowledge of the chemistry anddevelopmental process of in vivo imaging agents, experience with current analytical tools in both chemistry and biology, and a working knowledge of the issues associated with the information technology and cheminformatics required to successfully implement this database. The ability to extract and summarize scientific information in a textual format is essential. Contact Computercraft for details.
Fax: (301) 493-1288
CIP DCIDE PROGRAM
The Cancer Imaging Program of the NCI requests submissions for its Development of Clinical Imaging Drugs and Enhancers (DCIDE) initiative. The goal is the rapid movement of promising, novel cancer imaging enhancers or molecular probes from the laboratory to proof-of-principle clinical trials. See the web site for details.
The NIH Commons web site allows all NIH grantee organizations to interact with grants data, to check the status of grant applications, including viewing scores and summary statements when they are ready, and to submit progress reports on line, among a number of functions. Applicants and grants administrators should become familiar with the Commons.
ANNUAL CONFERENCE OF THE ACADEMY OF MOLECULAR IMAGING
March 25-29, 2006, Gaylord Palms Resort, Orlando, Fl URL: http://www.ami-imaging.org/
ASSOCIATION OF UNIVERSITY RADIOLOGISTS
April 5-8, 2006, Hilton Austin, Austin, Texas
NIH/JDRFI IMAGING THE PANCREATIC BETA CELL IN HEALTH & DISEASE, 3RD WORKSHOP
April 24-25, 2006, Loews L'Enfant Plaza Hotel, Washington, DC
Abstract submission to Lisa Berman at email@example.com
SCAR 2006 ANNUAL MEETING
Austin, Texas, April 27-30, 2006
SOCIETY OF NUCLEAR MEDICINE 53RD ANNUAL MEETING
San Diego, California, June 3-7, 2006
CARS 2006 COMPUTER ASSISTED RADIOLOGY AND SURGERY - 20TH INTERNATIONAL CONGRESS AND EXHIBITION
June 28 - July 1, 2006, Osaka Japan
SOCIETY OF MOLECULAR IMAGING Hilton Waikoloa Village, Hawaii, Hawaii, August 30-September 2, 2006
The Cancer Imaging Program at NCI has created this e-mail distribution list to notify interested people about funding opportunities and other issues related to imaging research. Its primary purpose is to call your attention to important, relevant information on NIH Web pages, or in the NIH Guide. Occasionally it may be used to clarify areas of confusion, or disseminate answers to frequently asked questions.
If you wish to remain on the list, no action is necessary. If you wish to be added to the list, please contact Ms. Johnnie Smith by return e-mail (firstname.lastname@example.org). Please include your complete mailing address, title, phone and fax numbers.
Cancer Imaging Program
Division of Cancer Treatment and Diagnosis, NCI
6130 Executive Boulevard - MSC-7412
Bethesda, MD 20892-7412
Tel: 301 496 9531
Fax: 301 480 3507